참고문헌
- Association CCoKOaG. Annual report of gynecologic cancer registry program in Korean for 2002. Korean J Obstet Gynecol 2005;48: 1130-1174
- Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-2041 https://doi.org/10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
- Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 198056:419-427
- Creutzberg CL, van Putten WLJ, Koper PC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecologic Oncology 2003;89:201-209
- Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology 2004;92:744-751 https://doi.org/10.1016/j.ygyno.2003.11.048
- Grigsby PW, Perez CA, Kuten A, et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 1992;22:905-911 https://doi.org/10.1016/0360-3016(92)90786-H
- Keum K, Lee C, Chung E, et al. Comparative analysis between preoperative radiotherapy and preoperative radiotherapy and postoperative radiotherapy in clinical stage I and II endometrial carcinoma. J Korean Soc Ther Radiol 1995;13:377-383
- Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65 https://doi.org/10.1016/0090-8258(91)90086-K
- Carey MS, O'Connell GJ, Johanson CR, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 199557: 138-144 https://doi.org/10.1006/gyno.1995.1115
- Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003;56: 1366-1372 https://doi.org/10.1016/S0360-3016(03)00414-0
- Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 1990;38:99-104 https://doi.org/10.1016/0090-8258(90)90018-G
- Cengiz M, Singh AK, Grigsby PW. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer. Int J Gynecol Cancer 2005;15: 926-931 https://doi.org/10.1111/j.1525-1438.2005.00156.x
- Greven KM, D'Agostino RB Jr, Lanciano RM, Corn BW. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-oonfined endometrial cancer? Int J Radiat Oncol Biol Phys 1998;42:101-104
- Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys 1990; 19:49-54 https://doi.org/10.1016/0360-3016(90)90133-5
- Rush S, Gal D, Potters L, Bosworth J, Lovecchio J. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma. Int J Radiat Oneal Biol Phys 1995;33:851-854 https://doi.org/10.1016/0360-3016(95)02012-8
- Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM. Should the presence of Iymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002;87:243-246 https://doi.org/10.1006/gyno.2002.6825
- Greven KM, Curran WJ Jr, Whittington R, et al. Analysis of failure patterns in stage III endometrial carcinoma and therapeufic implicafions. Int J Radiat Oncol Biol Phys 1989;17:35-39 https://doi.org/10.1016/0360-3016(89)90367-2
- Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. FIGO stage IIIC endomefrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiafion therapy. Gynecol Oncol 1999;75:211-214 https://doi.org/10.1006/gyno.1999.5569
- Potish RA, Twiggs LB, Adcock LL. Savage JE, Levitt SH, Prem KA. Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985;65:251-256
- Rose PG, Cha SD, Tak WK, Fitzgerald T, Reale F, Hunter RE. Radiation therapy for surgically proven paraaortic node metastasis in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1992:24:229-233
- Corn BW, Lanciano RM, Greven KM, et al. Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunifies for cure. Int J Radiat Oncol Biol Phys 1992:24: 223-227
- Cirisano FD Jr, Robboy SJ, Dodge RK, et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999;74:385-394 https://doi.org/10.1006/gyno.1999.5505
- Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study. Gynecol Oncol 1990;36:166-171 https://doi.org/10.1016/0090-8258(90)90166-I
- Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006:24:36-44 https://doi.org/10.1200/JCO.2004.00.7617
- Greven K, Winter K, Underhill K, et al. Final analysis of RTOG 9708: Adjuvant posfoperafive irradiafion combined wifh cisplatin/paclitaxel chemotherapy following surgery for patients wifh high-risk endomefrial cancer. Gynecol Oncol 2006;103:155-159 https://doi.org/10.1016/j.ygyno.2006.02.007